Main Article Content
For cardiovascular and musculoskeletal adaptations at the effort, it is necessary to establish borders of passage from normal to pathology. The main hormone that modifies the morpho-functional changes of the myocardium and vascular vessels in order to increase the cardiac output, as well as the proportional increase of the striated muscles and the tendons of insertion is the somatotrope. When growth hormone secretion is excessive, cardiac hypertrophy, arrhythmias, and possibly aneurysms and vascular accidents may occur. If endocrine adaptation to effort occurs with a deficient plasma level of the somatotropic, the risk of tendon rupture and possibly of tendon pain increases. In order to prevent these conditions, it would be useful to monitor the somatotropic plasma concentration in athletes, with the possibility of intervention to increase or decrease it.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Athletic Performance and Nutrition (JAPN) is published by MEDFITECH Inc. The views expressed in the papers are under the responsibility of author(s). All the intellectual property rights of the papers accepted for the publication belong to Journal of Athletic Performance and Nutrition indefinitely.